Single Domain Antibody Platforms Market Set to Reach US$ 62.3 Million by 2031, Growing at 9.5% CAGR Driven by Biopharmaceutical Innovations

18·09·2025

A Nanobody Specific to Prefusion Glycoprotein B Neutralizes HSV-1 and HSV-2

12·09·2025

Nanobody-Drug Conjugates: A New Direction for HER2 Cancer Therapy

25·08·2025

Innovative Bioluminescent Immunoassay for Rapid Fenpropathrin Detection Using Nanobody-Nanoluciferase Fusion Protein

18·08·2025

Biliary Tract Cancer Pipeline Outlook: Key Companies and Breakthrough Therapies Shaping the Future Landscape

14·08·2025

JSKN003: A Game-Changer in Platinum-Resistant Ovarian Cancer Treatment

06·08·2025